Digi-Tech Pharma & AI 2024
https://www.certara.com/conference/digi-tech-pharma-ai/
1493件の検索結果
Certara Regulatory Workshop in Korea
On-site Workshop Overview Regulatory approval procedures are becoming increasingly stringent and time-consuming. 適切な規制対応戦略を未構築のままでは、多くの時間と費用の浪費するだけでなく、最悪の場合には、開発計画の失敗や大幅な遅延に繋がる恐れがあります。It relayed to potential of Generative AI how it can help overcome those regulatory challenges. The emergence … Continued
https://www.certara.com/live-events/certara-regulatory-workshop-in-korea/Certara Announces Inaugural Client Conference with Keynote by Dr. Scott Gottlieb
Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies, and impact of generative AI on biosimulation and regulatory sciences RADNOR, PA– April. 18, 2024 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced that it will host the first-ever Certainty Conference. At this event, … Continued
https://www.certara.com/announcement/certara-announces-inaugural-client-conference-with-keynote-by-dr-scott-gottlieb/希少疾患治療薬開発の課題と機会
希少疾患における新たな治療薬の開発は、チャンスと複雑さの両方をもたらします。Because of the small patient pool available in these indications, there are challenges in designing and conducting clinical trials and the data interpretation that follows, and the ultimate path to registration. The top 3 critical downfalls in rare diseases development include Poor understanding of … Continued
https://www.certara.com/white-paper/the-challenges-and-opportunities-of-rare-disease-drug-development/Pinnacle 21 demo
Build Validated Studies Up To 85% Faster: With Pinnacle 21 See how to achieve faster drug development, with less effort, and less manual work. The Pinnacle 21 software suite augments your capabilities – helping you quickly build validated studies, get cleaner vendor data (minus the delays), automate SDTM, and speed time-to-analysis. Powered by technology, you’ll … Continued
https://www.certara.com/pinnacle-21-enterprise-software/demo/BIO KOREA 2024
https://www.certara.com/conference/bio-korea-2024/
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
PRINCETON, NJ – 2024年4月16日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to … Continued
https://www.certara.com/pressrelease/certara-launches-cloud-platform-to-further-unify-its-end-to-end-scientific-software-platform/Certara Announces New Corporate Headquarters
New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – 2024年4月15日 – Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 … Continued
https://www.certara.com/announcement/certara-announces-new-corporate-headquarters/What are biosimilars & how are they developed?
Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies demonstrate their bioequivalence to approved biosimilars.
https://www.certara.com/blog/what-are-biosimilars-how-are-they-developed/Chemicals
The chemicals industry has achieved remarkable innovations in various areas such as biodegradables, advanced battery materials, sustainable green energy solutions and additives to make carbon reduction processing in industrial uses. They are focused on recombining nature’s molecules to invent exciting new things and refine applications for existing products and components (as stated by Joshua Greenbaum, … Continued
https://www.certara.com/chemicals/